Efficacy and safety of intra-coronary administration of YM866 (modified tissue-type plasminogen activator) in patients with acute myocardial infarction

Japanese Pharmacology and Therapeutics

Volumn 24, Issue 11, 1996, Pages 143-166

  Haze, Kazuo ^a  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PAMITEPLASE; TISSUE PLASMINOGEN ACTIVATOR DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; MALE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030404464     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rentrop KP et al : Initial experience with transluminal recanalization of the recently occluded infarct-related coronary artery in acute myocardial infarction ; Comparison with conventionally treated patients. Clin Cardiol 2 : 92, 1979
2. Rentrop P et al : Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 63 : 307, 1981
3. Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardio (GISSI) : Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet i : 397, 1986
4. Sheehan FH et al : The effect of intravenous thrombolytic therapy on left ventricular function ; A report on tissue-type plasminogen activator and streptokinase from the thrombolysis in myocardial infarction (TIMI phase I) trial. Circulation 75 : 817, 1987
5. Chesebro JH et al : Thrombolysis in myocardial infarction (TIMI) trial, phase I ; A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 76 : 142, 1987
6. Topol EJ et al : Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction ; Improved timing, thrombolytic efficacy and ventricular function. J Am Coll Cardiol 10 : 1173, 1987
7. National Heart Foundation of Australia Coronary Thrombolysis Group : Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 hours after onset of myocardial infarction. Lancet i : 203, 1988
8. The GUSTO Investigators : An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329: 673, 1993
9. The GUSTO Angiographic Investigators : The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction . N Engl J Med 329: 1615, 1993
10. Seifried E et al ; Pharmacokinetics and haemostatic status during consecutive infusions of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction. Thromb Haemostas 61 : 497, 1989
11. Seifried E et al : Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteers. Arzneim Forsch 38 : 418, 1988
12. Katoh M et al : Biochemical and pharmacokinetic properties of YM866, a novel fibrinolytic agent. Thromb Haemostas 65 : 1193, 1991
13. Kawasaki T et al : Thrombolytic activity of a novel modified tissue-type plasminogen activator, YM866, in a canine model of coronary artery thrombosis. Jpn J Pharmacol 63 : 9, 1993
14. Ribeiro EK et al : Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardio 22 : 376, 1993
15. Popma JJ, Topol EJ : Adjuncts to thrombolysis for myocardial reperfusion. Ann Int Med 115 : 34, 1991
16. Hsia J et al : A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 323 : 1433, 1990
17. Bleich SD et al : Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction. Am J Cardiol 66 : 1412, 1990
18. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group : Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction, ISIS-2. Lancet ii : 349, 1988
19. Fung AY et al : Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction. Am J Cardiol 58 : 686, 1986
20. Topol EJ et al : A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. Circulation 75 : 420, 1987